Stephen FoulkesBenedict T. Costello, Erin J. Howden, Kristel Janssens, Hayley Dillon, Claudia Toro, Piet Claus, Steve F. Fraser, Robin M. Daly, David A. Elliott, Rachel Conyers & Andre La Gerche: Exercise cardiovascular magnetic resonance reveals reduced cardiac reserve in pediatric cancer survivors with impaired cardiopulmonary fitness. Journal of Cardiovascular Magnetic Resonance, volume 22, Article number: 64 (2020) 

Tim McOwan, Lauren Craig, Anne Tripdayonis, Kathy Karavendzas, Michael M. Cheung, Enzo R. Porrello, Rachel Conyers, David A. Elliott. Evaluating anthracycline cardiotoxicity associated single nucleotide polymorphisms in a paediatric cohort with early onset cardiomyopathy.Cardio-Oncology 2020 6:5, MS ID: CAON-D-20-00004R1

Lapirow D, La Gerche A, Toro C, Masango E, Costello B, Ludlow L, Marshall G, Trahair T, Mateos M,  Lewin J, Byrne J, Boutros R, Manudhane R, Heath J, Ayer J, Gabriel M, Walwyn T, Saundankar J, Forsey J, Le H, Mason K, Celermajer D, Downie P, Walker R, Holland L, Martin M, McLeman L, Marcocci M, Donath S, Cheung M, Porello E, Elliott DA and Conyers R: The Australia and New Zealand Cardio-Oncology Registry (ACOR): evaluation of chemotherapy-related cardiotoxicity in a national cohort of paediatric cancer patients. Internal Medicine Journal, ID: IMJ14719, DOI:10.1111/imj.14719, Internal Article ID: 16644346

Arasaratnam D, Bell KM, Sim CB, Koutsis K, Anderson DJ, Qian EL, Stanley EG, Elefanty AG, Cheung MM, Oshlack A, White AJ, Abi Khalil C, Hudson JE, Porrello ER & Elliott DA. The role of cardiac transcription factor NKX2-5 in regulating the human cardiac miRNAome. Sci Rep. 2019 Nov 4;9(1):15928. doi: 10.1038/s41598-019-52280-9

Tripaydonis A, Conyers R, Elliott DA. Pediatric Anthracycline-Induced Cardiotoxicity: Mechanisms, Pharmacogenomics and Pluripotent Stem-cell Modelling. Clin Pharmacol Ther. (2019) Mar;105(3):614-624. doi: 10.1002/cpt.1311. Epub 2019 Jan 11. Review.

Conyers R, Costello B, La Gerche A, Tripaydonis A, Burns C, Ludlow L, Lange P, Elkert P, Mechinaud F, Cheung M, Martin M and Elliott D. Chemotherapy-related cardiotoxicity: are Australian practitioners missing the point? Internal Medicine Journal 47 (2017): 1166-1172

Craig LA, Ekert PG, Conyers, Elliott DA. Genetic determinants of anthracycline cardiotoxicity- ready for the clinic? Br J Clin Pharmacol. (2017) May;83(5):1141-1142. doi: 10.1111/bcp.13195.

Tripaydonis A, Craig L, Ludlow LE, Cheung M, Mechinaud F, Ritchie D, Elliott D and Conyers R.  Building a Targeted Approach to Assess Risk of Anthracycline Induced Cardiomyopathy Amongst Paediatric Cancer Patients. Blood(2016):  128:5280. Abstract

Devaraja S and Conyers R. Systematic review of genetic polymorphisms associated with chemotherapy toxicity in paediatric cancer patients. Poster presentation. ANZCNS 6th Annual Scientific Meeting (2017).

Conyers R, Devaraja S and Elliott D. Systematic review of pharmacogenomics and adverse drug reactions in paediatric oncology patients. Pediatr Blood Cancer. 2018 Apr;65(4).

Toro C and ACOR Steering Committee. Determining the best indicator of cardiac reserve for paediatric and young adult cancer patients: the Extended Cardiac Evaluation Study (ECES). ANCHOG ASM (2019). Poster.

Conyers R, Masango E, Byrne J, Trahair T, Forsy J, Gabriel M, Toro C, Mandhane R, Saundankar J, Walwyn T, La Gerche A, Heath J, Ludlow L, Celermajer D, Marcocci M, Lockwood L, Boutros R, Donath S, Le H and Elliott D. The establishment of the Australian Cardio-Oncology Registry (ACOR): Improving cardiovascular health outcomes of paediatric, adolescent and young adults cancer patients and survivors. ANCHOG ASM (2019). Oral presentation 

Foulkes S and ACOR Steering Committee. Exercise cardiac MRI unmasks cardiac dysfunction in childhood and adolescent cancer survivors with reduced cardiopulmonary fitness. Cardiac Society of Australia and New Zealand Annual Scientific Meeting. (2019). Abstract.